BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
latest_posts
- 1
Faulty glucose monitors linked to 7 deaths and more than 700 injuries, FDA warns - 2Misinterpretations and Mistakes Portrayed by Hollywood in the General set of laws
- 3Pfizer says patient dies after receiving hemophilia drug in trial
- 4Map shows more than 1,900 measles cases across U.S.
- 5Step by step instructions to Involve Compact disc Rates for Magnanimous Giving
- Flu season is underway. What are common symptoms to watch for?
- The World's Dazzling Regular Miracles
- I'm 18 and founded an AI startup. I have to wake up at 3 a.m. to work on it before school, but it's worth every sleepless night.
- FDA proposes use of sunscreen ingredient popular in other countries
- Novo Nordisk justifies reasoning behind failed GLP-1 Alzheimer's trials
- Last Christmas, 3 million viewers watched a Chiefs love story — will Bills fans fall just as hard this year?
- The most effective method to Examine a Cellular breakdown in the lungs Finding with Family
- German foreign minister heads to China to talk rare-earth exports
- Pope Leo XIV calls for urgent climate action and says God’s creation is 'crying out'
